Firm will use CEER and mutational analysis platforms to help stratify patients to optimum therapies. Bayer Schering Pharma is tapping Prometheus Laboratories for mutational analyses services. Under ...
Panellists at the BIO International Convention in Boston this week expressed serious concerns about what the Mayo v Prometheus decision could mean for the Myriad gene patent case in its second round ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback